K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.4 HKD 0.47%
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Net Margin
Kangji Medical Holdings Ltd

54.5%
Current
60%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
54.5%
=
Net Income
534.4m
/
Revenue
980.8m

Net Margin Across Competitors

Country CN
Market Cap 7.8B HKD
Net Margin
54%
Country JP
Market Cap 6.8T JPY
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
12%
Country DK
Market Cap 179.6B DKK
Net Margin
19%
Country US
Market Cap 15.8B USD
Net Margin
11%
Country CN
Market Cap 51.5B CNY
Net Margin
42%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Net Margin
-358%
Country US
Market Cap 6.2B USD
Net Margin
29%
Country UK
Market Cap 4.5B GBP
Net Margin
7%
Country US
Market Cap 5.7B USD
Net Margin
9%
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.32 HKD
Undervaluation 38%
Intrinsic Value
Price
K

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
54.5%
=
Net Income
534.4m
/
Revenue
980.8m
What is the Net Margin of Kangji Medical Holdings Ltd?

Based on Kangji Medical Holdings Ltd's most recent financial statements, the company has Net Margin of 54.5%.